Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats

Certain live bacteria have demonstrated preliminary indications of efficacy for the treatment of chemotherapy-induced intestinal mucositis. However, probiotic derived supernatants (SN) have yet to be investigated in the mucositis setting. We evaluated SN from Escherichia coli Nissle 1917 (EcN) and L...

Full description

Saved in:
Bibliographic Details
Published inCancer biology & therapy Vol. 11; no. 7; pp. 671 - 677
Main Authors Prisciandaro, Luca D., Geier, Mark S., Butler, Ross N., Cummins, Adrian G., Howarth, Gordon S.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.04.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Certain live bacteria have demonstrated preliminary indications of efficacy for the treatment of chemotherapy-induced intestinal mucositis. However, probiotic derived supernatants (SN) have yet to be investigated in the mucositis setting. We evaluated SN from Escherichia coli Nissle 1917 (EcN) and Lactobacillus fermentum BR11 (BR11) for their capacity to decrease 5-Fluorouracil (5-FU)-induced damage in vivo. Female Dark Agouti rats were gavaged with 1mL of either SN or vehicle daily (days 0-8) and intraperitoneally injected with 5-FU (150mg/kg) on day 5 to induce mucositis. On day 9, animals were culled and intestinal tissues collected. Significantly lower histological damage scores were apparent in the jejunum of 5-FU treated rats receiving SN compared to 5-FU controls. Myeloperoxidase levels in the jejunum of 5-FU treated rats were increased in vehicle and BR11 SN treatments compared to untreated controls, whereas no significant increase was observed after EcN SN treatment. 5-FU treatment significantly reduced villus height and crypt depth in the jejunum compared to normal controls; however no significant reduction in these parameters was observed in 5-FU treated rats receiving either SN. We conclude that bacterial SN, especially EcN, partially protect the intestine from 5-FU mucositis. Further studies are required to define specific mechanisms by which SN exert their beneficial effects.
AbstractList Certain live bacteria have demonstrated preliminary indications of efficacy for the treatment of chemotherapy-induced intestinal mucositis. However, probiotic derived supernatants (SN) have yet to be investigated in the mucositis setting. We evaluated SN from Escherichia coli Nissle 1917 (EcN) and Lactobacillus fermentum BR11 (BR11) for their capacity to decrease 5-Fluorouracil (5-FU)-induced damage in vivo. Female Dark Agouti rats were gavaged with 1 mL of either SN or vehicle daily (days 0-8) and intraperitoneally injected with 5-FU (150 mg/kg) on day 5 to induce mucositis. On day 9, animals were culled and intestinal tissues collected. Significantly lower histological damage scores were apparent in the jejunum of 5-FU treated rats receiving SN compared to 5-FU controls. Myeloperoxidase levels in the jejunum of 5-FU treated rats were increased in vehicle and BR11 SN treatments compared to untreated controls, whereas no significant increase was observed after EcN SN treatment. 5-FU treatment significantly reduced villus height and crypt depth in the jejunum compared to normal controls; however no significant reduction in these parameters was observed in 5-FU treated rats receiving either SN. We conclude that bacterial SN, especially EcN, partially protect the intestine from 5-FU mucositis. Further studies are required to define specific mechanisms by which SN exert their beneficial effects.
Certain live bacteria have demonstrated preliminary indications of efficacy for the treatment of chemotherapy-induced intestinal mucositis. However, probiotic derived supernatants (SN) have yet to be investigated in the mucositis setting. We evaluated SN from Escherichia coli Nissle 1917 (EcN) and Lactobacillus fermentum BR11 (BR11) for their capacity to decrease 5-Fluorouracil (5-FU)-induced damage in vivo. Female Dark Agouti rats were gavaged with 1mL of either SN or vehicle daily (days 0-8) and intraperitoneally injected with 5-FU (150mg/kg) on day 5 to induce mucositis. On day 9, animals were culled and intestinal tissues collected. Significantly lower histological damage scores were apparent in the jejunum of 5-FU treated rats receiving SN compared to 5-FU controls. Myeloperoxidase levels in the jejunum of 5-FU treated rats were increased in vehicle and BR11 SN treatments compared to untreated controls, whereas no significant increase was observed after EcN SN treatment. 5-FU treatment significantly reduced villus height and crypt depth in the jejunum compared to normal controls; however no significant reduction in these parameters was observed in 5-FU treated rats receiving either SN. We conclude that bacterial SN, especially EcN, partially protect the intestine from 5-FU mucositis. Further studies are required to define specific mechanisms by which SN exert their beneficial effects.
Author Howarth, Gordon S.
Cummins, Adrian G.
Prisciandaro, Luca D.
Geier, Mark S.
Butler, Ross N.
Author_xml – sequence: 1
  givenname: Luca D.
  surname: Prisciandaro
  fullname: Prisciandaro, Luca D.
  email: luca.prisciandaro@adelaide.edu.au
– sequence: 2
  givenname: Mark S.
  surname: Geier
  fullname: Geier, Mark S.
– sequence: 3
  givenname: Ross N.
  surname: Butler
  fullname: Butler, Ross N.
– sequence: 4
  givenname: Adrian G.
  surname: Cummins
  fullname: Cummins, Adrian G.
– sequence: 5
  givenname: Gordon S.
  surname: Howarth
  fullname: Howarth, Gordon S.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21307648$$D View this record in MEDLINE/PubMed
BookMark eNqFUU2PFCEUJGaN-6FXj6ZvnrqFBhr6qJNVN9nEPaxn8pqGBEPDCLRm_v3SM-PGi_EC5FW9evWKa3QRYjAIvSW4Y2QgH_RUOkI60REmx-EFuiKc81ZyMVxsbypbhpm4RNc5_8C4F_0wvkKXPaFYDExeIfOQ4uRicbqxoEtMudlDKg68PzRu2af4y2wVWEwxFYy24a31a0xxTaCdb12YV23mxoVicnEBfLOsOmZXXK7FJkHJr9FLCz6bN-f7Bn3_fPu4-9ref_tyt_t432rO-tLOk7RAe27sqPVAgPF-lMxyTWRFpMQSGwETpSOMWMvKHI8nHyihRDB6g96fdKvvn2u1oxaXtfEegolrVnLAREjKSWV2J6ZOMedkrNont0A6KILVlqyqySpClFDHZGvDu7P0Oi1mfqb_ibISxhOhDptNrqFm7UzQ5i_lh1TtuIpDirtPj0f5_WxrL_lP7-Zm-xftzbOh8zwXbEwL_I7Jz6rAwcdkEwTtsqL_WOYJf3iySg
CitedBy_id crossref_primary_10_1186_s12934_017_0624_x
crossref_primary_10_3389_fphar_2021_755825
crossref_primary_10_1007_s00520_012_1446_3
crossref_primary_10_1007_s00520_013_1900_x
crossref_primary_10_1016_j_phanu_2020_100207
crossref_primary_10_1016_j_physbeh_2021_113411
crossref_primary_10_1186_s40168_018_0483_7
crossref_primary_10_3390_cancers13184623
crossref_primary_10_3945_jn_111_148924
crossref_primary_10_1007_s00520_013_1810_y
crossref_primary_10_1517_14712598_2014_874412
crossref_primary_10_1016_j_ijrobp_2022_03_036
crossref_primary_10_1080_01635581_2017_1263747
crossref_primary_10_1002_mnfr_201800728
crossref_primary_10_1186_s12866_023_03112_4
crossref_primary_10_1017_S0007114513004248
crossref_primary_10_1016_j_nut_2016_05_003
crossref_primary_10_1080_01635581_2015_990570
crossref_primary_10_1177_1535370213493718
crossref_primary_10_1016_j_tox_2021_152858
crossref_primary_10_1016_j_clnu_2016_11_017
crossref_primary_10_1016_j_bbrc_2021_11_005
crossref_primary_10_1177_2156587213477864
crossref_primary_10_1186_1477_5751_13_6
crossref_primary_10_3390_microorganisms10071418
crossref_primary_10_1007_s11481_021_10041_4
crossref_primary_10_1007_s11912_015_0474_9
crossref_primary_10_3389_fimmu_2021_704942
crossref_primary_10_1016_j_biopha_2021_112414
crossref_primary_10_3389_fmicb_2022_858036
crossref_primary_10_3390_ijms232315434
crossref_primary_10_1016_j_biopha_2020_111012
crossref_primary_10_1186_s13046_020_01715_7
crossref_primary_10_3389_fmicb_2020_544490
crossref_primary_10_1097_MCG_0b013e3182680201
crossref_primary_10_3389_fmicb_2018_00983
crossref_primary_10_1177_0023677215595554
crossref_primary_10_3389_fmicb_2021_623920
crossref_primary_10_1186_s40104_023_00869_6
crossref_primary_10_5582_ddt_2016_01059
crossref_primary_10_1007_s00280_014_2663_x
crossref_primary_10_1039_D2FO00226D
crossref_primary_10_1002_ame2_12262
crossref_primary_10_3390_jpm13101487
crossref_primary_10_3389_fmicb_2020_01941
crossref_primary_10_3389_fonc_2022_847350
crossref_primary_10_4161_cbt_28159
crossref_primary_10_3389_fphar_2021_755871
crossref_primary_10_2147_IJN_S244693
crossref_primary_10_3389_fphar_2017_00354
crossref_primary_10_1016_j_jneuroim_2020_577390
crossref_primary_10_3390_cancers11060857
crossref_primary_10_1080_01635581_2016_1158300
crossref_primary_10_3389_fimmu_2022_954885
crossref_primary_10_3389_fmicb_2018_02035
ContentType Journal Article
Copyright Copyright © 2011 Landes Bioscience 2011
Copyright_xml – notice: Copyright © 2011 Landes Bioscience 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4161/cbt.11.7.14896
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1555-8576
EndPage 677
ExternalDocumentID 10_4161_cbt_11_7_14896
21307648
10914896
Genre Research Paper
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
0R~
0VX
0YH
29B
30N
53G
5GY
6J9
AAAVI
AAJNR
ABBKH
ABCCY
ABEIZ
ABFIM
ABJVF
ACENM
ACGFO
ACGFS
ACTIO
ADBBV
ADCVX
AECIN
AEGYZ
AEISY
AENEX
AEXWM
AHDLD
AIJEM
AIRBT
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
AQRUH
AVBZW
AWQZV
BABNJ
BAWUL
BLEHA
C1A
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
EMOBN
F5P
H13
HYE
IH2
KSSTO
KYCEM
M4Z
O9-
OK1
P2P
P6G
RPM
SJN
TFL
TFT
TFW
TR2
TTHFI
ZGOLN
-
0R
AGCAB
AIRXU
RNANH
ROSJB
RTWRZ
TQWBC
AFPKN
AGYJP
CGR
CUY
CVF
ECM
EIF
NPM
TDBHL
4.4
AAYXX
ACKZS
ADFZZ
AURDB
BFWEY
CITATION
CWRZV
EJD
GROUPED_DOAJ
IPNFZ
LJTGL
PCLFJ
RIG
UDS
7X8
ID FETCH-LOGICAL-c542t-db8fa325ef9cc61a452984f5c18b8f88080e7ab339a90c83259c8325563131743
ISSN 1538-4047
IngestDate Fri Oct 25 06:56:11 EDT 2024
Fri Aug 23 03:08:07 EDT 2024
Sat Sep 28 08:37:49 EDT 2024
Fri Jan 15 03:37:24 EST 2021
Tue May 21 11:32:50 EDT 2019
Tue Jul 04 18:14:55 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c542t-db8fa325ef9cc61a452984f5c18b8f88080e7ab339a90c83259c8325563131743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.4161/cbt.11.7.14896?needAccess=true
PMID 21307648
PQID 860178351
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_860178351
crossref_primary_10_4161_cbt_11_7_14896
informaworld_taylorfrancis_310_4161_cbt_11_7_14896
pubmed_primary_21307648
landesbioscience_primary_cbt_article_14896
PublicationCentury 2000
PublicationDate 4/1/2011
2011/04/01
2011-Apr-01
2011-04-00
20110401
PublicationDateYYYYMMDD 2011-04-01
PublicationDate_xml – month: 04
  year: 2011
  text: 4/1/2011
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer biology & therapy
PublicationTitleAlternate Cancer Biol Ther
PublicationYear 2011
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
SSID ssj0027269
Score 2.2773495
Snippet Certain live bacteria have demonstrated preliminary indications of efficacy for the treatment of chemotherapy-induced intestinal mucositis. However, probiotic...
SourceID proquest
crossref
pubmed
landesbioscience
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 671
SubjectTerms Animals
Binding
Biology
Bioscience
Calcium
Cancer
Cell
Cycle
Enzyme Activation
Female
Fluorouracil
Intestinal Mucosa - metabolism
Intestinal Mucosa - microbiology
Intestinal Mucosa - pathology
Intestine, Small - enzymology
Intestine, Small - microbiology
Landes
Mucins - metabolism
Mucositis - chemically induced
Mucositis - metabolism
Organogenesis
Peroxidase - metabolism
Probiotics
Proteins
Rats
Severity of Illness Index
Sucrase - metabolism
Title Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats
URI https://www.tandfonline.com/doi/abs/10.4161/cbt.11.7.14896
http://www.landesbioscience.com/journals/cbt/article/14896/
https://www.ncbi.nlm.nih.gov/pubmed/21307648
https://search.proquest.com/docview/860178351
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZtCqU99P3YvtChUGhx6pds-ZiENqE0IYcN5GYkWYLA7npx7ED76zsjyY9dstD2YhZpJYHm00gzmvlEyEdk9YJdgwdpFeogzZQMCgHrSmopRVpokTBMcD49y04u0h-X7HL06drsklbuq9-35pX8j1ShDOSKWbL_INmhUyiA3yBf-IKE4ftXMj63JEpIudo_m7PGf4nF4hemPzb1jcYSscSYFxuzwQKz6OoGOhfqahGAQd5hAACSRsBax5PpEkPYkejIZroIR_Q04TJQuvnSMzchbNpNWoLzBtN8rXvCOmF_dkqMUcXH-spBBFOERq_rIUYl-UBvVLzDxQjMpfeHH1QNqqLjqZcC3a5DcIv2mpWxgDP32MugeqMJxPKJHs3cuyzb-h2tMRCKki2o-v0c1Dx37-FOhL1eWmnHsDnnmWPx3GLU7qvuknsxqCfUi0l4NprpcVY4ek8c7uvmYJY82jXfOMls8Nw-JI8xLBVv-Dwjqd5twNiDzPwJeeQtEHrg4PSU3NGrZ-T-qY-xeE70gCrqUUUHVFGPKjqiitaG3o4qOqKKDqiCQoqoekEuvn-bH50E_jGOQLE0boNKciOSmGlTKJVFAi_seWqYijjUcKQn1bmQSVKIIlSwT7DCflmWRAmavS_J3qpe6deECjhURqbi0pg4lUwWFVjtIaiGiIeqSNiMfOontlw7zpUSbFWURgnSAKO1zEsrjRmJp_NettbLZdyTNGWys9G2dCbDTJfJ0eHcNltXZkY-72yE3Xsd0I9Ae2GXoK3xCk6sdN1dlzyDHRCMnmhGXjkQDL30sHqzs-YteTAurXdkr206_R6OxK38YBH8B2umvJw
link.rule.ids 315,783,787,27936,27937,60214,61003
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIvE4UN4sTx-QkJCy5GEnjjhBRbVAd9XDVuoBybIdW1qxTVa72QP8emacBNqKvfSSgyPbsj0znudngLeE6oW3hox4FbuI59ZEpUa-Ms4YzUunM0EFztNZPjnl387E2R58HGphKK2SbGjfAUUEWU3MTc5o4nDSxz9Y0yKrjwtkc1nmN-BmTshfVL8Rz_5ZW2l4zy5wNI950SE2_qf_pRvpEl7pXTig9EKK1PTIkm63IhoupKMD-DEspctD-TnetmZsf19BebzmWu_DvV5RZZ86ynoAe65-CLemfSj-EbiTgOCEf1n_Zg9bERnq5fIXWwRXhaMWfU4JNxvWeCYiv9w2axxZ28UyWtQV0lXFCLECBQ3Ndk7584SyhI0MaXPzGE6PvswPJ1H_ZkNkBU_bqDLS6ywVzpfW5ommuK7kXthE4h9JKJau0CbLSl3GFsWJKMNX5FmSkXX0BPbrpnbPgGnUPRJfSeN9yo0wZYXGXYwUlMjYlpkYwbvh3NSqg-ZQaNLQrincNbRtVKHCro0gvXisqg3OEN-9XKKynZ2uHv6FaU7WVDQdnD3N4ed56Laq_Aje7-xEw_fiYJiBDbSkkKkpUqNr12w3SqKZTC65ZARPOxr7O0qKSkeRc_n8Omt6A7cn8-mxOv46-_4C7nT-ccpCegn77XrrXqGC1ZrXgZH-AAWvJQE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Lb9MwGP8EQ5rgwHhTnj4gISGlJLGdOEcYVOOxqodNmsTBsh1bquiSqk0P8NfzfU4K20Qvu-TgyLbs7-Hv5Z8B3hCqF54aKhF16hNROJtUBuXKemuNqLzhki44H0-Lo1Px9UyeDVWV66Gsknzo0ANFRF1Nwr2sAwk4mePvne1Q0sclSrmqiptwC02AlHicp9N_zlYen7OLAi1SUfaAjf_pf-lAugRXegcOqLqQEjUDsKTfbYfG82hyAD-2K-nLUH6ON50du99XQB6vt9R7cHcwU9mHnq_uww3fPID94yER_xD8LOI34V82vNjDlsSEZrH4xeYxUOGpxZxTuc2atYHJJCw27QpHNm6-SOZNjVxVM8KrQDVDs51T9TxhLGEjQ85cP4LTyeeTw6NkeLEhcVLkXVJbFQzPpQ-Vc0VmKKurRJAuU_hHEYalL43lvDJV6lCZyCp-ZcEzTr7RY9hr2sY_BWbQ8shCrWwIubDSVjW6dinyT6ZSV3E5grdbsullD8yh0aGhXdO4a-jZ6FLHXRtBfpGquouhkNC_W6L5zk5XaX9hmtmKrkzHUE97-PEkdkOyjeDdzk40_KAMtjOwLStpFGnK05jGt5u1VugkU0AuG8GTnsX-jpKjyVEWQj27zppew_7s00R__zL99hxu98FxKkF6AXvdauNfonXV2VdRjP4Ahywjrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Probiotic+factors+partially+improve+parameters+of+5-fluorouracil-induced+intestinal+mucositis+in+rats&rft.jtitle=Cancer+biology+%26+therapy&rft.au=Prisciandaro%2C+Luca+D&rft.au=Geier%2C+Mark+S&rft.au=Butler%2C+Ross+N&rft.au=Cummins%2C+Adrian+G&rft.date=2011-04-01&rft.eissn=1555-8576&rft.volume=11&rft.issue=7&rft.spage=671&rft_id=info:doi/10.4161%2Fcbt.11.7.14896&rft_id=info%3Apmid%2F21307648&rft.externalDocID=21307648
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-4047&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-4047&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-4047&client=summon